Technicians don't like to read the papers, so Greg Harmon is looking at the action in big cap...

|By:, SA News Editor

Technicians don't like to read the papers, so Greg Harmon is looking at the action in big cap pharma stocks and it's telling him they're going to like the outcome of the Supreme Court ruling on Obamacare. Bristol-Myers (BMY), Eli Lilly (LLY), Merck (MRK), and Pfizer (PFE) - all yielding nearly 4% or more - are all on the verge of long-term breakouts.